TECX Q2 2019 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$634M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$200,000

Operating Income

-$17M

Net Income

-$16M

EPS (Diluted)

$-8.01

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$102M

Total Liabilities

$9M

Stockholders' Equity

$93M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$200,000	-$45,000	-344.4%
Operating Income	-$17M	-$10M	-74.0%
Net Income	-$16M	-$11M	-52.8%